Share
Market Research Report

BREAST CANCER LIQUID BIOPSY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Circulating BiomarkersCirculating Tumor Cells (CTCs) · Circulating Cell-free DNA (cfDNA) · Extracellular Vesicles (EVs) · and Other Circulating Biomarkers
  • By ApplicationEarly Detection/Screening · Diagnosis · Treatment Selection · and Monitoring
  • By GeographyNorth America · Latin America · Europe · Asia Pacific · Middle East · and Africa
  • Published In18 Nov 2026
  • Report CodeCMI10439
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  • Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  • Market Overview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Circulating Biomarkers
      • Market Snapshot, By Application
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  • Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Product Approval
    • Collaboration/Merge/Acquisition
    • Regulatory Landscape
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Epidemiology
    • Robust Pipeline Analysis
  • Global Breast Cancer Liquid Biopsy Market, By Circulating Biomarkers, 2021 – 2033, (USD Million)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022– 2033
      • Segment Trends
    • Circulating Tumor Cells (CTCs)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
    • Circulating Cell-free DNA (cfDNA)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
    • Extracellular Vesicles (EVs)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
    • Other Circulating Biomarkers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
  • Global Breast Cancer Liquid Biopsy Market, By Application, 2021 – 2033, (USD Million)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022– 2033
      • Segment Trends
    • Early Detection/Screening
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
    • Diagnosis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
    • Treatment Selection
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
    • Monitoring
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
  • Global Breast Cancer Liquid Biopsy Market, By Region, 2021 – 2033, (USD Million)

    • Introduction
      • Market Share Analysis, By Region, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Regions, 2022–2033
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Circulating Biomarkers, 2021 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Circulating Biomarkers, 2021 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Circulating Biomarkers, 2021 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Circulating Biomarkers, 2021 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Circulating Biomarkers, 2021 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Circulating Biomarkers, 2021 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Million)
        • North Africa
        • Central Africa
        • South Africa
  • Competitive Landscape

    • Heat Map Analysis
    • Market Share Analysis
    • Company Profile
      • The Menarini Group
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • NeoGenomics Laboratories
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • F. Hoffmann-La Roche Ltd.
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Myriad Genetics, Inc.
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Thermo Fisher Scientific, Inc.
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • QIAGEN, Biocept, Inc.
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Sysmex Corporation
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Fluxion Biosciences, Inc.
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Epic Sciences, Inc.
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
    • Analyst Views
  • Section

    • References
    • Research Methodology
    • About Us